首页> Liver international : official journal of the International Association for the Study of the Liver> Loss of Mtarc1 Protects Against Steatotic Liver Disease in Mice.

Loss of Mtarc1 Protects Against Steatotic Liver Disease in Mice.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiaofei,Yin

第一单位： Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

作者： Xiaofei,Yin ^[1] ; Caroline,Bickerton ^[1] ; Bryan,MacDonald ^[1] ; Alessandro,Arduini ^[1] ; Yunlong,Shi ^[2] ; Mary,Haas ^[1] ; Amy,Deik ^[3] ; Mark,Chaffin ^[1] ; Erika,Kovacs-Bogdan ^[1] ; Julian Avila,Pacheco ^[3] ; Maiwen,Amegadjie ^[1] ; Bidur,Bhandary ^[1] ; Shayan,Sadre ^[1] ; Thomas,Rathjen ^[4] ; Irinna,Papangeli ^[2] ; Raymond T,Chung ^[5] ; Russell,Goodman ^[6] ; Melina,Claussnitzer ^[1] ; Clary,Clish ^[3] ; Alexander,Ehrmann ^[7] ; Alison,Leed ^[8] ; Patrick T,Ellinor ^[9]

作者单位： Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. ^[1] Bayer U.S. LLC, Cambridge, Massachusetts, USA. ^[2] Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. ^[3] Bayer AG, Pharmaceutical Division, Berlin, Germany. ^[4] GI Division, Department of Medicine, Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. ^[5] GI Division, Department of Medicine, Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.;Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA. ^[6] Bayer AG, Pharmaceutical Division, Wuppertal, Germany. ^[7] Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. ^[8] Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.;Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA. ^[9]

关键词 Mtarc1 metabolic dysfunction‐associated steatotic liver disease phospholipid profibrosis steatosis